Liver Cancer Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action ...
Promising Liver Cancer Therapies such as Atezolizumab, Bevacizumab, Tiragolumab, OH2 injection, MTL-CEBPA, Sorafenib 200mg, ...
Liver Cancer Therapeutics Market to Hit USD 15.69 Billion by 2032, growing at a CAGR of 19. ...
Liver Cancer Therapeutics Market Growth is Driven by Advancements in Precision Medicine, Immunotherapy and Growing Global Incidence.Pune, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Liver Cancer Therapeutics ...
Pharmaceutical Technology22 小时
FDA grants fast track status to Rznomics’ RZ-001 for HCC
The US FDA has granted fast track designation to Rznomics' RZ-001 for the treatment of hepatocellular carcinoma (HCC).